Joemed Technologies

We are a digital therapeutics company with innovational solution to offer the airway diseases’ patients with “ less symptoms, higher lung functions, less exacerbation rates”. It is a new breakthrough in the whole airway diseases world that Asthma and COPD patients can use their individual and clear graphical target “the BLFP” for evaluating the treatment efficacy and for long-term management Asthma and COPD modules launched in mainland China, will launch in global soon… Through daily monitoring data(2-4weeks) collected by JoeMed APP and our portable lung function device, combined with self-monitoring symptoms and scheme of treatment, the “Chronotherapy strategy” will offer a therapeutic intervention to help patients optimizing the care, getting sufficient treatment and rapidly achieving individuals’ “best lung function plateau”(BLFP). Keeping in the range of the BLFP to reduce the exacerbation risks replaces” detecting and treating at the early beginning of exacerbation”! The BLFP is a clear graphical target range easy to be understood by both doctors and patients for evaluating treatment efficacy and for long-term management. Sparse check at home with our home-used APP and device, make sure the lung function in the range of the “BLFP”,pre-intervene if needed could effectively reduce the asthma exacerbation risks and rates.